Custom Lentiviral Dual sgRNA Knockout Construct (plasmid) from Cellecta

Get Quote

Get Quote from
Cellecta for
Custom Lentiviral Dual sgRNA Knockout Construct (plasmid)

Supplier Page

Description

The CRISPR/Cas9 system can be used for knocking out gene expression in vivo or in vitro by using a combination of an sgRNA (single guide RNA, or gRNA) along with a Cas9 nuclease. Achieve permanent 100% knockout in your cell line by using Cellecta’s lentiviral-based CRISPR sgRNA constructs.